Various Radiopharmaceuticals W81K00-25-Q-A125
Summary
AI-generated · Aug 23, 2025Provide radiopharmaceuticals to the Brooke Army Medical Center Nuclear Medicine Clinic on an as-needed basis under a Firm-Fixed-Price IDIQ, with a base period of one year and four consecutive option years. Bidders must be able to supply the COMPLETE LIST of radiopharmaceuticals identified in Attachment 1; pricing is not requested at the sources-sought stage. Submit a 3-page Capability Statement showing the ability to furnish the full list to BAMC, plus your organization’s name, CAGE code, address, point of contact, phone, and e-mail. Indicate if the requirement can be met through an existing contract vehicle (for example, a VA contract).
Between notices, a formal RFQ is planned for Radiopharmaceuticals for BAMC, with full-and-open competition and a multi-year IDIQ contract (one base year plus four option years) expected to begin a multi-year performance window after award. The RFQ will reference the same radiopharmaceuticals list in Attachment 1 and will be posted on SAM.gov. The procurement will be for the complete list specified, with no pricing in response to the sources-sought notice, and will be open to competition from both small and large businesses.
The Medical Readiness Contracting Office - West (MRCO-W) has an upcoming requirement for various radiopharmaceuticals to be provided on an as-needed basis to the Nuclear Medicine Clinic at Brooke Army Medical Center (BAMC) located at JBSA Fort Sam Houston, TX (refer to Attachment 1 for list of radiopharmaceuticals required). The Government anticipates issuing an IDIQ contract for this requirement, which will include a twelve-month base period plus four (4) twelve-month option periods. Responses to the Sources Sought Notice should demonstrate the firm's ability, capability, and responsibility in providing the COMPLETE LIST of various radiopharmaceuticals listed in Attachment 1. Do not submit pricing information in response to this Sources Sought. Interested sources should submit a Statement of Capability (3 page limit) detailing their capability to provide the radiopharmaceuticals to Brooke Army Medical Center (JBSA Fort Sam Houston, TX). Additionally, please provide the following information: 1) Organization's name, CAGE code, address, point of contact, phone number, and e-mail address. Please advise if the requirement can be met through a contract vehicle the source already has (i.e VA FSS contract number). ************************************ The purpose of this synopsis is to gain knowledge of interest, capabilities and qualifications of various members of the Small Business Community to include Section 8(a), Historically Underutilized Business Zones (HUB-Zone), Women-Owned Small Business, and Service-Disabled Veteran-Owned Small Business (SDVOSB), as well as the interest, capabilities and qualifications of various members of the Large Business community, to compete and perform a Firm Fixed Price (FFP) IDIQ contract for these radiopharmaceuticals. The type of solicitation to issue will depend upon the responses to this sources sought synopsis. The Government must ensure there is adequate competition among the potential pool of responsive contractors. THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. This notice does not constitute a commitment by the Government. All information submitted in response to this announcement is voluntary, and the Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the Government.
From Sources Sought posted on Jun 24, 2025This pre-solicitation notice is prepared and provided in accordance with FAR Part 5; it serves as the synopsis for Solicitation W81K00-25-Q-A125. The Government anticipates the release of a written Request for Quote (RFQ) for Radiopharmaceuticals (refer to Attachment 1 for list of radiopharmaceuticals required) in support of Brooke Army Medical Center (BAMC), JBSA Fort Sam Houston, TX. The solicitation release date is anticipated to occur on or around 20 AUG 2025 and will be posted to SAM.gov. The solicitation will be issued using full-and-open competition. The resultant contract will be an IDIQ contract inclusive of one (1) base year plus four (4) option years, with a period of performance beginning on 01 OCT 2025 and an ultimate completion date of 30 SEP 2030. Solicitation PSC/NAICS 6505 (Drugs and Pharmaceutical Products) / 325412 (Pharmaceutical Preparation Manufacturing)
From Presolicitation posted on Aug 12, 2025Notice history
2-
Sources Sought Posted Jun 24, 2025
-
Presolicitation LATEST Posted Aug 12, 2025View changes (3)
- Description: Description was updated
- Notice Type: Sources Sought → Presolicitation
- Response Deadline: Jul 01, 2025 → Aug 19, 2025
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA